PROF · Profound Medical Corp.
$6.85
+0.07 (+1.03%)
At close · Jul 17
Market Cap
$248.91M
Shares
36.34M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.85
Open$6.70
Day$6.64–6.97
52W$3.76–8.95
Avg vol 30d69K
Short int2.1M · 5.7% float · 35.1d
Short vol42%
Last earningsMay 7, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Up next
Next earnings call
Jul 27, 2026
Est · unconfirmed
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 18.8 · elevated
Equity put/call 0.73
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+2%
above
Price vs 50-day avg
−0%
below
RSI (14)
49
neutral
MACD trend
Negative
52-week position
60%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+4%
trailing
6-month return
−14%
trailing
YTD return
−13%
this year
Relative strength
−22%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $7 — 50d above 200d
Institutional flow
Distributing
2 of 58 funds reported for Jun 30 · net -297 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.69% of float · ▼ -3.5% MoM · 35.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
58 holders — mid 3-yr range
Squeeze score
64
elevated · 0–100
Fundamentals
Revenue growth
+51%
Y/Y
Gross margin
71%
expanding
EPS growth
+26%
Y/Y
Free cash flow
$-38.4M
Valuation
P/E 5.5
below peers
Balance sheet
$53.5M
net cash
Quant / Vol
risk profile
Volatility
72%
annualized · 1-yr
Max drawdown
−42%
past year
ATR
5.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 7, 2026
Total revenue
· full-year 2026
Initiated
$25M
prior FY $16.1M
midpoint +55.3% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+2%
Bullish
Price vs 50-day avg
−0%
Neutral
RSI (14)
49
Neutral
MACD trend
Negative
Bearish
52-week position
60%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $7 › 200d $7 — 50d above 200d
Institutional flow
Distributing
2 of 58 funds reported for Jun 30 · net -297 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.69% of float · ▼ -3.5% MoM · 35.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
58 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $4
Now $7 · 60%
52-wk high $9
vs 200-day avg +2%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PROF
this stock
Profound Medical Corp.
|
$248.91M | -13.0% | +50.7% | 5.5 | 5.7% |
|
ABT
Abbott Laboratories
|
$175.37B | -19.2% | +5.7% | 28.2 | 1.3% |
|
SYK
Stryker Corp
|
$122.63B | -8.7% | +11.2% | 37.0 | 1.8% |
|
MDT
Medtronic plc
|
$106.50B | -12.7% | +8.4% | 22.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.44B | -53.8% | +5.5% | 18.4 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PROF | -2.7% | +4.3% | -13.9% | +3.0% | -13.0% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | -1.2% | +4.0% | -21.8% | +3.5% | -22.0% |